CoQ10 and wrinkles around the eyes

Study result for water-soluble Q10Vital and measured wrinkle area.

Key points

  • In healthy women aged 45–60, water-soluble Q10Vital reduced the measured area of wrinkles around the eyes compared with placebo over 12 weeks. For this product and duration there is a preliminary signal of a possible reduction in wrinkle area around the eyes. [1] See the evidence 1
  • The study used the specific water-soluble product Q10Vital, and CoQ10 forms in supplements differ. When comparing products, check the composition and form of each specific product. [1] [2] See the evidence 1 2

Practical guide

Check the conclusions and whether they apply to your situation.

The study assessed a specific product and an appearance measure.

Key points

Why these conclusions

The Q10Vital study

Healthy women aged 45–60 received water-soluble CoQ10 Q10Vital in syrup at 50 or 150 mg daily or placebo syrup for 12 weeks. Measured wrinkle area around the eyes decreased compared with placebo; certainty is very low. [1]

Ubiquinone and ubiquinol are different CoQ10 forms; interconversion does not mean that products are interchangeable. [2]

In a small study, concentrations after 100 mg of ubiquinone with cyclodextrin and standard ubiquinone were compared in 21 participants; the difference in blood concentrations does not prove clinical superiority of either formulation. [3]

In women aged 45–60, water-soluble Q10Vital reduced the measured area of wrinkles around the eyes compared with placebo over 12 weeks.

ParameterData
ResultIn women aged 45–60, water-soluble Q10Vital reduced the measured area of wrinkles around the eyes compared with placebo over 12 weeks. p=0.04 for each dose versus placebo.
Participants33 healthy women aged 45–60, three groups of 11
FormWater-soluble CoQ10 Q10Vital orally in syrup
Dose50 or 150 mg/day
Dose basis50 or 150 mg/day
ComparatorPlacebo syrup
Duration12 weeks
Confidence1/4: Precision: Small samples, intervals and uncertain clinical significance. Consistency: Insufficient data for a separate downgrade. Applicability to the specified group: The stated form, outcome, clinical context and population limit transferability. Possible publication bias: Insufficient data for a separate downgrade. Study methods: Limitations in assessing design, reporting or losses.
Evidence base1 trial; outcome from the same participant group
Sources[1]

Ubiquinone and ubiquinol are different CoQ10 forms; interconversion does not mean that products are interchangeable.

Ubiquinone and ubiquinol are different CoQ10 forms; interconversion does not mean that products are interchangeable. [2]

In a small study, concentrations after 100 mg of ubiquinone with cyclodextrin and standard ubiquinone were compared in 21 participants; the difference in blood concentrations does not prove clinical superiority of either formulation.

In a small study, concentrations after 100 mg of ubiquinone with cyclodextrin and standard ubiquinone were compared in 21 participants; the difference in blood concentrations does not prove clinical superiority of either formulation. [3]

More details

How to compare products

A specific water-soluble product was studied; check the form and composition of another supplement. [2] [1]

Sources

  1. The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study. https://pubmed.ncbi.nlm.nih.gov/27548886/
  2. FDA UNII registry record: UBIDECARENONE (UNII EJ27X76M46). https://precision.fda.gov/ginas/app/ui/substances/EJ27X76M46
  3. Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals. https://pmc.ncbi.nlm.nih.gov/articles/PMC7146408/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Ubidecarenone